Shares of IperionX Limited Sponsored ADR (NASDAQ:IPX – Get Free Report) have received an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell rating and six have assigned a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $42.00.
A number of analysts have recently weighed in on IPX shares. Jefferies Financial Group began coverage on shares of IperionX in a research note on Wednesday, September 2nd. They issued a “buy” rating and a $26.00 price objective for the company. B. Riley Financial dropped their price target on shares of IperionX from $52.00 to $34.00 and set a “buy” rating for the company in a research note on Wednesday, September 30th. Roth Capital set a $53.00 price objective on IperionX in a research note on Wednesday, August 5th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of IperionX in a report on Thursday, October 15th.
Get Our Latest Report on IperionX
IperionX Price Performance
IperionX stock opened at $14.10 on Friday. IperionX has a 1-year low of $12.14 and a 1-year high of $61.45. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.95 and a current ratio of 3.24. The stock’s 50 day moving average price is $17.29 and its 200 day moving average price is $29.64.
IperionX (NASDAQ:IPX – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The company reported ($0.50) EPS for the quarter. Equities analysts anticipate that IperionX will post -0.34 EPS for the current year.
Hedge Funds Weigh In On IperionX
Institutional investors have recently modified their holdings of the company. Connective Capital Management LLC bought a new position in IperionX during the 2nd quarter valued at $160,000. GAMMA Investing LLC raised its position in IperionX by 40.3% during the second quarter. GAMMA Investing LLC now owns 1,681 shares of the company’s stock valued at $50,000 after acquiring an additional 483 shares in the last quarter. DLD Asset Management LP acquired a new position in IperionX during the first quarter worth approximately $260,000. Finally, Private Advisor Group LLC increased its holdings in IperionX by 69.9% during the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company’s stock worth $1,643,000 after buying an additional 25,964 shares during the last quarter. Institutional investors own 2.76% of the company’s stock.
IperionX Company Profile
IperionX Limited (NASDAQ: IPX) is a critical minerals and advanced materials company focused on producing low-carbon titanium products in the United States. The company is developing domestic sources of titanium minerals and technologies intended to convert titanium feedstocks into titanium metal, powder and other advanced materials.
IperionX’s primary development asset is the Titan Project in Tennessee, which contains titanium, zircon and other heavy mineral sands. The company is also developing proprietary processing technologies, including the Hydrogen-Assisted Metallothermic Reduction (HAMR) process and the Titanium Alloy Production (TAP) process, with the goal of manufacturing titanium products using less energy than conventional production methods and incorporating recycled titanium where practical.
The company targets customers in industries such as aerospace, defense, medical devices, automotive, consumer products and additive manufacturing.
Recommended Stories
- Five stocks we like better than IperionX
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for IperionX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IperionX and related companies with MarketBeat.com's FREE daily email newsletter.
